{"id":"https://openalex.org/W2018050810","doi":"https://doi.org/10.1016/0306-3623(91)90325-z","title":"Protective effects of minaprine in infarction produced by occluding middle cerebral artery in stroke-prone spontaneously hypertensive rats","display_name":"Protective effects of minaprine in infarction produced by occluding middle cerebral artery in stroke-prone spontaneously hypertensive rats","publication_year":1991,"publication_date":"1991-01-01","ids":{"openalex":"https://openalex.org/W2018050810","doi":"https://doi.org/10.1016/0306-3623(91)90325-z","mag":"2018050810","pmid":"https://pubmed.ncbi.nlm.nih.gov/1675616"},"language":"en","primary_location":{"id":"doi:10.1016/0306-3623(91)90325-z","doi":"https://doi.org/10.1016/0306-3623(91)90325-z","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0306-3623(91)90325-z","pdf_url":null,"source":{"id":"https://openalex.org/S3961818","display_name":"General Pharmacology The Vascular System","issn_l":"0306-3623","issn":["0306-3623","1879-0011"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"General Pharmacology: The Vascular System","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110113221","display_name":"Shigeru Okuyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigeru Okuyama","raw_affiliation_strings":["Department of Pharmacology, Taisho Pharmaceutical Co., Ltd, Saitama, Japan","Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Taisho Pharmaceutical Co., Ltd, Saitama, Japan","institution_ids":["https://openalex.org/I144245601"]},{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010267160","display_name":"Hiroko Shimamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroko Shimamura-Harada","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011528476","display_name":"Yasuko Karasawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuko Karasawa","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028464483","display_name":"Kazuaki Kawashima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuaki Kawashima","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112659639","display_name":"Hiroaki Araki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroaki Araki","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Masaaki Kimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaaki Kimura","raw_affiliation_strings":["Department of Toxicology, Research, Center Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Toxicology, Research, Center Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112817015","display_name":"Susumu Otomo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Susumu Otomo","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111532471","display_name":"Hironaka Aihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hironaka Aihara","raw_affiliation_strings":["Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd, 1-403, Yoshino-cho, Ohmiya, Saitama 330, Japan","institution_ids":["https://openalex.org/I144245601"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I144245601"],"apc_list":null,"apc_paid":null,"fwci":0.7651,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.67584603,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"1","first_page":"143","last_page":"150"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.7943999767303467,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.7943999767303467,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.19099999964237213,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14144","display_name":"Neurological Disease Mechanisms and Treatments","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/minaprine","display_name":"minaprine","score":1.0},{"id":"https://openalex.org/keywords/cerebral-infarction","display_name":"cerebral infarction","score":0.8730000257492065},{"id":"https://openalex.org/keywords/middle-cerebral-artery-occlusion","display_name":"middle cerebral artery occlusion","score":0.9539999961853027},{"id":"https://openalex.org/keywords/stroke-prone-spontaneously-hypertensive-rats","display_name":"stroke-prone spontaneously hypertensive rats","score":0.9629999995231628},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.8399999737739563},{"id":"https://openalex.org/keywords/infarct-size","display_name":"infarct size","score":0.8339999914169312},{"id":"https://openalex.org/keywords/cerebral-ischemia","display_name":"cerebral ischemia","score":0.8100000023841858},{"id":"https://openalex.org/keywords/cerebral-cortex","display_name":"cerebral cortex","score":0.34200000762939453},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C2775841333","wikidata":"https://www.wikidata.org/wiki/Q498179","display_name":"Middle cerebral artery","level":3,"score":0.8102133274078369},{"id":"https://openalex.org/C2776268601","wikidata":"https://www.wikidata.org/wiki/Q968808","display_name":"Occlusion","level":2,"score":0.7183773517608643},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.664704442024231},{"id":"https://openalex.org/C2779450755","wikidata":"https://www.wikidata.org/wiki/Q1209150","display_name":"Cerebral infarction","level":3,"score":0.6083968281745911},{"id":"https://openalex.org/C2777798775","wikidata":"https://www.wikidata.org/wiki/Q207550","display_name":"Infarction","level":3,"score":0.5971534848213196},{"id":"https://openalex.org/C2781041448","wikidata":"https://www.wikidata.org/wiki/Q75839","display_name":"Cerebral cortex","level":2,"score":0.5356796383857727},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.4833216667175293},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3778497874736786},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3004249930381775},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.2956598997116089},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.09654781222343445},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001784","descriptor_name":"Blood Gas Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002536","descriptor_name":"Cerebral Arteries","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D002544","descriptor_name":"Cerebral Infarction","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002544","descriptor_name":"Cerebral Infarction","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002544","descriptor_name":"Cerebral Infarction","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D002561","descriptor_name":"Cerebrovascular Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011918","descriptor_name":"Rats, Inbred SHR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0306-3623(91)90325-z","doi":"https://doi.org/10.1016/0306-3623(91)90325-z","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0306-3623(91)90325-z","pdf_url":null,"source":{"id":"https://openalex.org/S3961818","display_name":"General Pharmacology The Vascular System","issn_l":"0306-3623","issn":["0306-3623","1879-0011"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"General Pharmacology: The Vascular System","raw_type":"journal-article"},{"id":"pmid:1675616","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1675616","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"General pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W191075690","https://openalex.org/W1967568884","https://openalex.org/W1971879046","https://openalex.org/W1978136238","https://openalex.org/W1984677855","https://openalex.org/W1990859892","https://openalex.org/W1997331097","https://openalex.org/W1997852999","https://openalex.org/W2002330209","https://openalex.org/W2009874687","https://openalex.org/W2011788145","https://openalex.org/W2018121672","https://openalex.org/W2027355567","https://openalex.org/W2031710238","https://openalex.org/W2045835005","https://openalex.org/W2056987304","https://openalex.org/W2064906534","https://openalex.org/W2069099106","https://openalex.org/W2077389603","https://openalex.org/W2091442789","https://openalex.org/W2115884259","https://openalex.org/W2155300117","https://openalex.org/W2317574587","https://openalex.org/W2319318108","https://openalex.org/W2338398103","https://openalex.org/W2417731354","https://openalex.org/W2431828046","https://openalex.org/W3147490713"],"related_works":["https://openalex.org/W2431828046","https://openalex.org/W2078196498","https://openalex.org/W3141263650","https://openalex.org/W3146602036","https://openalex.org/W2029813615","https://openalex.org/W2338398103","https://openalex.org/W2014815659","https://openalex.org/W1969605298","https://openalex.org/W2077831615","https://openalex.org/W2021889565"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}